Proactive Investors - Run By Investors For Investors

Asterion Cannabis applies for medicinal cannabis licences in Queensland

The Vancouver-based medicinal cannabis grower’s Queensland facility will be the world's largest greenhouse cannabis operation, covering a 99-acre site
A woman holding a marijuana leaf and CBD oil
Asterion has filed an application with the Australian Government Office of Drug Control to obtain licences

Asterion Cannabis Inc, a private Canadian company, said this week that its wholly-owned Australian subsidiary has filed an application with the Australian Government Office of Drug Control to obtain licences for the cultivation, production and research of medicinal cannabis.

The medicinal cannabis research licence would allow Asterion Australia to begin developing standard operating procedures for its research platform and to start research into clonal propagation techniques. 

These cultivation and production licences are expected to allow the company to begin “controlled growing” of cannabis plants, and to formulate medicinal cannabis-derived bulk active pharmaceutical ingredients, said the company.

The active pharmaceutical ingredients are expected to be formulated as pharmaceutical salts and, separately, for incorporation into various dosage forms, including tablets, capsules, oral wafers, patches, creams, oral sprays or topical soluble gels.

READ: Asterion Cannabis' Australian unit strikes agreement to acquire land for Queensland production facility

Asterion Australia has struck up a non-binding agreement to acquire about 90 hectares of farmland in South East Queensland for the production of medicinal cannabis for more than C$10 million.

The ambitious project will ultimately have an annual capacity in excess of 500,000 kilograms. 

This facility will be home to the world's largest greenhouse cannabis operation, covering a 4.3 million square foot site (approximately 99 acres).

To be built in three phases, the Asterion facility will be automated and powered by renewable energy. It will also include full extraction and processing equipment, as well as an R&D wing to create next-generation medicinal cannabis products.

The facility will use special plant tissue culture technology that will eliminate the need for mother plants, increase efficiency, lower costs and yield disease-free plantlets.

Asterion is a privately held Canadian cannabis company with operations in Australia that specialises in organic medical cannabis.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full AC profile View Profile

Asterion Cannabis Inc Timeline

Related Articles

The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
cannabis extract
January 17 2019
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
November 03 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use